If you can't stand the heat--don't trade on the OTC. this is the "wild, Wild West" of stock trading. Daily manipulation by traders--they are savvy and know how to scare those into selling who don't understand the way OTC stocks see-saw up and down. OWCP just announced amazing news on Monday, seems to be on track to bring a breakthrough drug to market later this year--and peeps look at paper losses and freek out. Yes, some of the big believers have gotten a little carried away, but I am in for the long haul, try to nibble on a few more shares on days like today and sell a little when the stock runs up big. I can't be too upset losing 45k today since I have 70k shares @ 0.55 and have crushed the market this year. I have my big 3 otc stocks--owcp, vdrm and imlff and vdrm had a nice run up today to cut my losses a bit. I will sleep like a baby tonight and hope for this sell off was so those in the know could load up for,the next leg up.
Glta
Sam

No announcement by Inmed on term sheet agreement. Only by rvvtf. This is only the intent of an agreeement--no details on how much $$ Inmed will receive. IF they sign the agreement and provide details of payments, hopefully the pps will move. More importantly, I think this validates inmed's potential at making money on their proprietary cannabaloids discovery technology for other companies.
Rvvtf sounds like a solid company--2 drugs already in clinical trials at mass general in Boston and nyu school of medicine in nyc--I bought a small position at market open today.
Sam

My own mmj mini-etf: owcp, vdrm, imlff. There is lots of money to be made investing in pharmaceutical companies working on unlocking the power of cannabaloids. I have been invested in Inmed for 2 years--probably got in a bit early--but I really think this will explode this year. Holding 300k shares at 0.21. Started buying owcp at 0.40--now averaged up to 0.53 with 69k shares. Told a little profit on the way up yesterday and this morning. And now have 700k shares of vdrm at 0.017. These 3 stocks are 70% of my portfolio--and given the volitility of otc stocks--having 3 stocks that can shoot up has protected me when one of the stocks has a big down day. Owcp was running hard yesterday, and vdrm's big day today buffered owcp down day.
I believe that all 3 companies have huge long term potential and will provide me with financial security to work part time and really enjoy my life.
A little surprised that inmed's news today did not move the stock, but I guess it's a non-binding intent and not a partnership yet.
Today was a wild ride for,owcp--but we are up big,over the last 2 days. I,this this one has legs.
Sam

special meeting--reverse stock split? just conjecture--but maybe the conference in nyc brought a big investor-partner, but not at this share price. any other thoughts? possible uplisting requires higher share price?
sam

an original idea. 2 stocks similar to imlff. I have been long Inmed since the days it was trading only 12000 shares daily and in the red big time. Thanks to averaging down--now my cost is $.21/share--I am up a bit and very hopeful the price will explode with meaningful news. Acceptance of cannabis by the medical and pharmaceutical community is happening! Do your own DD, but mine helped me find 2 more stocks on the verge of similar breakthroughs as Inmed. Both are based outside of the us and are working on real products. Very active boards here where you can find lots of information and opinions to sift thru.
1. Owcp
2. Vdrm
GLTA
Sam

Is this run just from the bott appointment? Stock up just 15% yesterday in Canada. Up big time on both exchanges today. Is there something else brewing?
Sam

Canadian market trading today-Inmed up 15% now. Expect similar move tomorrow when US markets open. I think this new Lilly connection will bring in a lot of new investors, just look at all the new peeps on this board in the last few days. No guarantees but all least big pharma is noticing us now!
ITs been a rough ride over the past few years, but I am so happy I keep my shares and hopefully will now reap the benefits.
http://thecse.com/en/listings/life-sciences/inmed-pharmaceuticals-inc
Sam

Neutra Health Services Vancouver partner Oceanview Health Services is the only possible association to Inmed that I could find, since they both are Vancouver based. There is another web site that refers to Inmed as a subsidiary of neutra-so I wonder if one got it wrong and the other just copied it. Neutra sounds pretty shady.
Sam

IMLFF--similar opportunity to OWCP. New ties -LIlly?
I am a new investor to owcp--long term investor in IMLFF. I found the similarities striking. Since the new CEO came aboard last year, they seem to be making connections and appointing seasoned pharma execs to,their board. Just appointed the Vp of investments at Eli Lilly to their board! Chief scientist and co-founder worked at GW Pharm. I like the medical-pharmacological cannabaloid companies for potential long term gains.
Do,your own dd. Lots of information on their Ihub board.
Sam

http://seekingalpha.com/instablog/12862651-les-mezei/4949578-four-long-term-penny-stock-picks-profitable-2017
http://finance.yahoo.com/news/inmed-pharmaceuticals-appoints-martin-bott-213600273.html;_ylt=A0LEV0hbZ3tYacQAoiTBGOd_;_ylu=X3oDMTEzbTRvcG83BGNvbG8DYmYxBHBvcwMxBHZ0aWQDVFBSREMwXzEEc2VjA3Ny

Recent news by first company in article-imlff. Just appointed the Vp of finance for investments from Eli Lilly to their board--this could be the potential strategic investment they will Need to move forward with clinical trials. Canadian based so no US schedule one issues for now. Do your own dd, but I am focused on preclinical stage companies utilizing the medical-pharmacological properties of cannabaloids--and soon big pharma will too! Just started a position in owcp--teva seems to be watching that one closely.
http://finance.yahoo.com/news/inmed-pharmaceuticals-appoints-martin-bott-213600273.html;_ylt=A0LEV0hbZ3tYacQAoiTBGOd_;_ylu=X3oDMTEzbTRvcG83BGNvbG8DYmYxBHBvcwMxBHZ0aWQDVFBSREMwXzEEc2VjA3Ny
Sam

3 new filings on cse by inmed- hope?
http://thecse.com/en/listings/life-sciences/inmed-pharmaceuticals-inc
Scroll down and you will see 3 recent filings--looks mostly like using stock-warrants to pay debt. Last form 9 is a bit confusing to me. Is this private placement and assumption of debt owed to brennan?
Maybe these filings are reason stock tixed up yesterday--especially with heavy volume on cse. Maybe peeps who sold recently are getting back in.
And if you go to inmeds web page and look at the may presentation, it has clinical trials starting this year.
Is it possible this new company looking to unlock shareholder value is doing in one month what brennan failed to do in his tenure?
Still a long way to go, but some activity is better than silence.
Sam

Clinical trials in 2016? See updated corporate presentation--has management changes and still indicates clinical trials this year. What gives?
http://www.inmedpharma.com/i/pdf/presentations/presentation.pdf
They still need lots of new $$ to start trials.

Again showning premarket trade--191k shares at .22
http://www.otcmarkets.com/stock/IMLFF/quote
Since the company is canandian based--any employee related exchanges would be done on the canadian market. Is it possible that previous financing in us had an exit clause if stock dropped below a certain pps. Since this has been goin on all week--something is happening. Dont want to get my hopes up but given the lack of good news lately, its at least interesting. Anyone have a better explanation?
Sam

I think its a glitch--yahoo finance had the closing price premarket Monday at 0.21.
Why would anyone buy at .18-.21 when the pps is half that?
Btw, chris bogurt bought another 25000 canadian shares last week. His last buys in february did not pan out--so i am not hopeful that this buy means too much. Just reporting.
https://m.canadianinsider.com/company?menu_tickersearch=IN%20%7C%20InMed%20Pharmaceuticals
Sam

Comparing mmj and what inmed is targeting is apples to oranges. if i understand inmeds approach--they have a way to identify which cannabaloids are most effective in treating a specific disease. smoking or injesting cannabis is a much broader approach--and especially when injesting-there are so many variables. smoking is not a delivery option of choice for many individuals seeking treatment. inmed also claims that their proprietary system will speed up the time (and reduced cost) from clinical trials to product approval. whether they can take what works in vitro and with mice to human application-and find a partner or funding source is another barrier. i guess its all about leadership and if you believe the braintrust can be as successful with cannabaloid based treatments as they were in previous pharmaceutical ventures. high risk-potential high reward.
sam